Showing posts with label Apollo Hospitals. Show all posts
Showing posts with label Apollo Hospitals. Show all posts

Saturday, September 28, 2019

Apollo Hospitals signs MoU with Samsung's spinoff Wellysis for cardiac care

Apollo Hospitals Group has signed a Memorandum of Understanding (MoU) with Wellysis, a spinoff company of Samsung SDS South Korea, to develop, manufacture and commercialise cardiac wellness, diagnostic, monitoring and therapeutic devices. The joint venture will be set up in Chitoor, Andhra Pradesh.

The MoU was signed by Rick Hongryul Kim, CTO/CMO and co-founder, Wellysis and Hari Prasad, group president, Apollo Hospitals Group.

Apollo Hospitals has set up over 40 cardiac command centres across its medical institutions and any doctor across the country can register to gain access to the knowledge and experience of over 300 cardiologists across the group's ecosystem. The centre has modern connected technologies enabling Tele ECH Monitoring, CICU monitoring, Tele ECHO Monitoring , Remote Cathlab and ER Response Module. It will also have facilities for training and development, and a management dashboard for tracking and control.

Sangita Reddy, joint managing director, Apollo Hospitals Group, said, “Our country has only 4,000 cardiologists as compared to the 88,000 that we should ideally have. It is a huge gap and the best way to start covering it is through technology. The goal of this initiative is to come together, witness, discuss and learn from each other new ways of addressing cardiology. Robotics, AI, Tele-cardiology… these are some things we know happening today. The cardiac command centre with high-end screening tools, along with the National Cardiac Registry, will form the foundation of the battle against cardiovascular diseases.”

The Cardiac Command Centre will provide an opportunity to physicians in urban and semi-urban settings, standalone clinics/nursing homes, national/state medical associations, government institutions, and new-age start-ups in the cardiovascular space to join this network and gain access to knowledge and experience, said Preetha Reddy, vice chairperson, Apollo Hospitals Group.

A Futuring Cardiac Care Summit, organised with support from partners including GenWorks, Abbott and HealthNet Global, is a one of kind platform that aims to eradicate the high risks of cardiovascular diseases and discover integrated solutions to screen and detect such complications more efficiently, it added.

GenWorks Health Pvt Ltd, a Wipro GE Healthcare invested company, has also partnered with the Apollo Command Centre and said that in a pilot run, it could advise 25,000 patients suffering chest pains and located as far as away as 2,000 km from the centre. It could also guide general practioners on providing appropriate care to patients and offer support and intervention, if the need arose. GenWorks Health claims it has saved the lives of 25 patients.

Tuesday, September 17, 2019

Apollo Hospitals launches artificial intelligence-based programme

Apollo Hospitals has launched a preventive health care programme with the support of artificial intelligence (AI) to offer health care management through its 370 centres across the country, including its hospitals and clinics.

The company is expected to gradually expand this business in a tie-up with other nursing homes and hospitals across the country, senior officials of the company said.

The programme, designed for three years now, would offer health check ups, directions and health mentoring, based on the test results and free consultations to the customers to prevent health care issues proactively with the use of an app and wearables.

The company will be charging Rs 6,000 in the first year, Rs 5,000 in second while Rs 4,000 in the third year.

Apollo Hospitals Chairman Prathap C Reddy said the company would be looking at expanding the offer through nursing homes and other hospitals across the country in a later stage.

The company has tied up with UK-based DXC Technology to work on the artificial intelligence based on 20 million health checks conducted by Apollo Hospitals.

Speaking to the reporters, Reddy commented on the economic slowdown stating while there is a hiccup in terms of economic growth, Indians are strong from within and the determinent leader will help the country to grow better.

The company will work with the government on its health care programmes to offer services to the people, Reddy said.

Monday, September 16, 2019

Apollo Hospitals to seek shareholders' nod for hiving off pharmacy biz

Apollo Hospitals Enterprise Ltd (AHEL) will convene a meeting of equity shareholders on October 21, based on the orders from National Company Law Tribunal (NCLT), for the approval of a scheme of arrangement to transfer the front end of its pharmacy business to a separate company called Apollo Pharmacies Ltd (APL).

APL is expected focus on the goal of achieving Rs 10,000 crore in revenues and 30 per cent combined Return On Capital Employed (ROCE) for the standalone pharmacy business in five years.

Currently, AHEL holds 100 per cent of the equity share capital of Apollo Medicals Private Limited (AMPL), which in turn holds all the equity shares in APL. Once the Scheme of Arrangement is implemented, AHEL’s shareholding in AMPL would be diluted to 25.5 per cent of the share capital of AMPL with while the rest of the stake would be with other Investors of AMPL. This include Jhelum Investment Fund I (19.9 per cent shareholding), Hemandra Kothari (9.9 per cent) and ENAM Securities Private Limited (44.7 per cent) of AMPL, which would in turn hold 100 per cent equity share capital of APL.

AHEL would be the exclusive supplier for APL under a long-term supply agreement and further would also enter into a Brand Licensing Agreement with APL to licence the “Apollo Pharmacy” brand to the front end stores and online pharmacy operations, to further augment and strengthen the brand, with these arrangements. APL will pay a lump sum of Rs 527.8 crore to AHEL in the form of cash through normal banking channels, once the Scheme comes into effect.

"Apollo Pharmacy today has grown from 170 outlets in FY05 to 3,428 outlets as of March 31, 2019, in 400 cities/towns spread over 20 states and 4 Union territories and is currently serving about 300,000 customers daily through dedicated employee strength of about 21,000 plus," said the company.

The proposed reorganisation would not have a material impact on the financials of AHEL as the backend business related to the stand alone pharmacies which represents around 85 per cent of the business economics will continue to be held by AHEL, it added.

The Scheme would help AHEL to utilise the proceeds of divestment towards growth and enhancement of other existing businesses, allow it to have dedicated management focus on each businesses among others.

It would help APL to acquire ready-to use assets, including business undertakings and reducing time to markets, enhancing private label business from the current over 6 per cent to over 12 per cent in next five years and enable foray into digital or online pharmacy, said the company.

Organised pharmacy retail accounts for less than 5 per cent of India’s $15 billion domestic pharmaceutical market which is estimated to grow 10-12 per cent compound annual growth rate over the next decade, driven predominantly by volume growth, driven by the domestic pharmaceutical industry include increasing disposable incomes, demand for quality products, higher incidence of chronic diseases, growing awareness of diagnostics and preventive care, and greater accessibility through generics. Organised pharmacy retail is expected to grow at a much faster rate within this, it added.

Thursday, September 12, 2019

Apollo Hospitals promoter group will issue 50 lakh shares to reduce stake

The promoter group family of Apollo Hospitals Enterprise Ltd (AHEL) will be issuing five million shares through secondary placement to raise around $101 million (Rs 720 crore).

The aim is to reduce the promoters' pledged shares in the company. The deal, for which Citi Group is acting as placement agent and building the book (the term for getting enough investors to buy into a new share issue), is expected to happen in a day or two.

A combination of foreign and domestic institutional investors are expected to participate, said sources. The floor price is Rs 1,450 a share. Around 3.6 per cent of all shares in the company would be covered and Rs 750 crore is expected, going by the floor price, said market sources.

After the sale, promoter group shares will come down to around 30.8 per cent of the total equity, from the current 34.4 per cent. Withthis and the money to come through sale of stake in Apollo Munich Helath Insurance, the company is expected to bring down the promoter group's pledged shares to around 20 per cent.

The latter deal, said company sources, was expected to be consummated next month. Bringing down the stake is a commitment the promoters had made to minority shareholders.

Wednesday, July 17, 2019

Family running Apollo Hospitals seeks investors, assets sale to pay debt

The family that controls Apollo Hospitals Enterprise Ltd., India’s largest private hospital chain, is looking to sell assets or bring an outside investor into their holding company to pay down debt.

The aim is to reduce the Apollo shares pledged by the family as collateral to lenders, to 20per cent of their total holding in the company from about 78per cent now, said Suneeta Reddy, Apollo’s managing director and one of the four daughters of founder Prathap Reddy. The Reddy family owns about 34per cent of Apollo’s stock.

“The idea is to do something that’s good for all shareholders of Apollo. If it means reducing our pledge, we are committed to doing that,” she said in an interview with Bloomberg. “We will see what the family can do.”

Shares of the Chennai-based company closed 0.5per cent lower on Monday after rising as much as 2.7per cent during trading. The benchmark S&P BSE Sensex advanced 0.2per cent.

In February, Apollo saw its share price plummet as a credit crunch across India’s financial sector spurred fears that companies whose controlling shareholders had pledged a large proportion of their holdings could be in danger of bulk selling if they defaulted. Subhash Chandra’s Essel Group and Anil Ambani-controlled firms also faced investor concerns.

Pledged Ratio

Apollo’s stock has recovered since then, gaining nearly 10per cent this year. The Reddy family has sold off its share in a health insurance venture with Munich Re Group that it says will bring its pledged ratio down to between 35per cent and 40per cent by September. The family has given itself about a year to get the pledge ratio of its Apollo holding down further to 20per cent, Suneeta Reddy said.

Among the assets the family could sell are a chain of 13 nursing colleges and two medical colleges it owns. The family has spent 3 billion rupees ($43.6 million) building the education venture and it is expected to turn profitable next year, Reddy said.

Another fundraising avenue the family is exploring is bringing an investor directly into its holding company, PCR Investments Ltd., which may replace the 5.5 billion rupees in debt securities lent by private-equity giant KKR & Co. that recently matured, she said.

“People are talking to us,” Reddy said. She declined to specify what kind of investor they are looking for, other than that it will be someone “who has an understanding of health care” or wants to get into the business. “It will be long term,” she added.

The Reddys are also working to reduce debt at Apollo itself, with proceeds from the insurance sale and a plan to spin off its chain of retail pharmacies expected to bring long-term debt down to 25 billion rupees by the end of the year from about 30 billion rupees currently. Reddy said the company expects to announce another deal to raise cash and pay down the debt further sometime this month, declining to specify details.